By - Anzar Alam

Molecular Diagnostics refers to Laboratory medicine or laboratory tests to identify a disease by analyzing the DNA or RNA or their Protein in Humans.
The Molecular Diagnostics era began at the time of the discovery of double-helical DNA structure in 1953 by Watson and Crick.

In the mid-1980s, southern blot transfer hybridization assay was in major part of molecular diagnostic laboratories, technical armamentarium for current an application such as the detection of gene deletion in Duchenne and muscular dystrophy and repeat expansion in fragile X syndrome. 
Originally southern blot was primarily used in linkage analysis for cystic fibrosis and other genetic diseases. The southern blot assay became a gold standard test that was used to detect many human gene sequences by the use of specific restriction endonuclease and also used for mutation detection and gene arrangement. GenProb Inc. became the first US Company to provide the FDA-approved probe-based diagnostic test for the detection of infectious agents (Chlamydia trachomatics and Neisseria gonorrhea). While many laboratories were using various forms of blotting techniques to make their entry into 
the molecular diagnostic arena, the limitations of these technologies were with respect to sensitivity, specificity, and turnaround time.

Human Genome Project: The molecular revolution began in October 1990 when the Human Genome Project took off. It is important because it uses information from DNA to develop new ways to treat, cure, or even prevent the thousands of diseases that afflict humankind. A major milestone in the early 1990s was the transition of the polymerase chain reaction (PCR) from the research laboratory to the clinical laboratory. But the road from gene identification to effective treatment is long and fraught with challenges. In 1990-2003 the 13 years of long journey completed the human genome project as a result of this development of genomics in human health treatment; the field of genomics medicine was born. All diseases have molecular components the success of the Human Genome Project has enabled researchers to pinpoint errors in genes, the smallest unit of heredity that cause or contribute to disease.

Transition to Clinical Laboratories: Research laboratories introduced an era of genomics as a molecular diagnostic to the physician for better understanding the disease on a molecular level and making personalized health. The technological advancement will continue to play an important journey in the Practice of medicine, public health, Pharmaceutical industry to get personalized medicine and forensics science. Some of these genomics technologies include DNA Sequencing, Microarray, polymerase chain reaction (PCR), Fluorescent in situ hybridization (FISH), Karyotype, Peptide nucleic acids (PNA), and electrochemical detection of DNA, Nanotechnology, and Proteomics. Most of the applications are for infections but are now in the area of increasing genetic disorders, pre and postnatal diagnostic, Pre-implantation genetic screening, and cancer.

Genomics Medicine and Personalized Health: The integration of genomics into healthcare has ushered in a new era of personalized medicine, transforming the way diseases are understood, diagnosed, and treated. This revolutionary approach harnesses the power of an individual's genetic information to tailor medical interventions, providing targeted and more effective healthcare strategies.

1.  Precision Diagnosis: Genomics enables a deeper understanding of an individual's genetic makeup, allowing for precise diagnosis of diseases. This is particularly evident in the identification of genetic markers associated with various conditions, aiding in early detection and accurate diagnosis.

2.   Targeted Therapies: By analyzing genetic variations, healthcare professionals can identify specific molecular targets for treatment. This has led to the development of targeted therapies, which are designed to act on the underlying causes of diseases at the genetic level. These therapies often result in more effective and less invasive treatments with fewer side effects.

3.  Predictive Medicine: Genomic data empowers healthcare providers to predict an individual's susceptibility to certain diseases. This proactive approach allows for early interventions, lifestyle modifications, and personalized preventive measures to reduce the risk of developing specific conditions.

4.  Pharmacogenomics: Understanding how an individual's genetic makeup influences their response to medications is a key aspect of genomics medicine. Pharmacogenomics helps tailor drug prescriptions to a patient's unique genetic profile, optimizing treatment outcomes and minimizing adverse reactions.

Success Stories in Genomics Medicine:

1.   Cancer Treatment Personalization: Genomics has revolutionized cancer treatment by enabling targeted therapies based on the specific genetic mutations driving a patient's tumor. For example, the drug imatinib has shown remarkable success in treating chronic myeloid leukemia by targeting the BCR-ABL fusion gene.

2.  Inherited Diseases Screening: Genomic information has been instrumental in identifying and managing inherited diseases. Newborn screening programs now utilize genomics to detect genetic disorders early, allowing for timely interventions and improved outcomes.

3.   Rare Diseases Diagnosis: Genomic sequencing has facilitated the diagnosis of rare and undiagnosed diseases. Patients with conditions that were once mysterious or misdiagnosed can now receive accurate diagnoses, paving the way for more targeted and effective treatment plans.

4.    Personalized Cancer Vaccines: Advancements in genomics have led to the development of personalized cancer vaccines. These vaccines are tailored to a patient's specific tumor mutations, triggering an immune response against cancer cells and showing promise in enhancing cancer treatment outcomes.

Proteomic-Based Testing: Proteomic-based testing represents a cutting-edge frontier in medical diagnostics, focusing on the comprehensive analysis of proteins within biological systems. This advanced approach goes beyond genomics, providing crucial insights into the dynamic and functional aspects of proteins. From disease detection to therapeutic advancements, proteomic-based testing holds immense promise in reshaping the landscape of modern healthcare.

Future Outlook:

The future of molecular diagnostics is poised to revolutionize healthcare by offering unprecedented insights into individualized disease management and treatment. Several key trends and advancements are anticipated in the coming years.

Cost-effective Genome Sequencing: A breakthrough on the horizon is the prospect of cost-effective and rapid genome sequencing. Within the next decade, individuals may have their entire genomes sequenced at a fraction of today's cost. This transformative shift could empower patients with comprehensive genetic information for personalized healthcare.

Advanced Sequencing Technologies: The continuous evolution of sequencing technologies, such as next-generation sequencing (NGS) and emerging methods, promises higher accuracy, faster turnaround times, and expanded capabilities for detecting a wide range of genetic variations. These advancements will contribute to more precise diagnostics.

Integration of Molecular Diagnostics with Therapeutics: The ultimate goal in the future is the seamless integration of molecular diagnostics with therapeutic interventions. Patients could carry compact DNA chips containing their genetic information, enabling clinicians to tailor treatments based on individual genetic profiles. This personalized approach holds the potential to enhance treatment efficacy and safety.

Lab-on-a-Chip Technology: The development of integrated chip devices, often referred to as "lab-on-a-chip," is anticipated to streamline genetic readouts from single cells and molecules. This miniaturization of diagnostic tools could enhance efficiency and reduce costs, making molecular diagnostics more accessible.

Proteomic-based Testing: Advances in proteomic-based testing will complement genomic insights, providing a more comprehensive understanding of disease mechanisms. This holistic approach could lead to improved diagnostic accuracy and the identification of new therapeutic targets. 

FDA-Approved Genetic Tests: The increasing number of FDA-approved genetic tests commercially available is indicative of the growing acceptance and reliability of molecular diagnostics. This trend is likely to continue, with more tests becoming validated and approved for clinical use.

Predictive Genomics and Disease Management: As the field progresses, predictive genomics will become a cornerstone of disease management. Understanding an individual's genetic predispositions will not only facilitate early diagnosis but also enable proactive interventions to prevent the onset or progression of certain diseases.

In conclusion, the future of molecular diagnostics holds exciting possibilities for transforming healthcare into a more personalized, precise, and effective system. As technology advances, overcoming current challenges and embracing these innovations will lead to a paradigm shift in the way we approach diagnostics, treatment, and overall patient care. The integration of genomics into routine medical practice is not just a vision; it is a tangible and promising future that will shape the landscape of healthcare.

Don't forget to share!

Please join our WhatsApp Channel and follow us on Social Media @biotechville for instant/daily job updates.

Disclaimer:

The views expressed in this article are solely those of the author(s) and do not necessarily represent the official stance of BiotechVille. The content is opinion-based and not intended to malign any organization or individual. BiotechVille does not guarantee the completeness, accuracy, reliability, suitability, or availability of the information in this article. Any reliance on such information is at your own risk. BiotechVille reserves the right to edit or remove content at its discretion.